Andrew Kocab 5/31/21 Andrew Kocab 5/31/21

Building Better Vaccines: Iaso Therapeutics

Learning how Iaso Therapeutics is developing a new vaccine platform to protect us from new and existing disease threats.

Andrew Kocab 5/2/21 Andrew Kocab 5/2/21

Creating a Company Around Genetically Engineered Probiotics: ZBiotics & Zack Abbott, PhD

Zack’s journey to creating a company and the world’s first genetically engineered probiotic.

Andrew Kocab 3/21/21 Andrew Kocab 3/21/21

The value of relationships in fundraising.

Andrew Kocab 2/28/21 Andrew Kocab 2/28/21

Lessons on how the ONL team pitched our story to investors.

Andrew Kocab 2/14/21 Andrew Kocab 2/14/21

Key lessons for fundraising from the CEO of ONL Therapeutics.

Andrew Kocab 10/25/20 Andrew Kocab 10/25/20

Learning about fundraising from Melissa, who has been involved with fundraising for the University of Michigan and the ACLU.

Andrew Kocab 9/27/20 Andrew Kocab 9/27/20

Learning about how Devin and his firm think about risk in biotech.

Andrew Kocab 7/12/20 Andrew Kocab 7/12/20

Studying the long-lasting and impactful consequences of obesity on the immune system.

Andrew Kocab 4/19/20 Andrew Kocab 4/19/20

A second dive into the Michigan drug development ecosystem.